Myllia Biotechnology
@mylliabio
Primary cell CRISPR screens to accelerate drug target discovery and genetic screening for cellular phenotypes at single-cell resolution
ID: 1141339667146653696
http://www.myllia.com 19-06-2019 13:39:16
77 Tweet
92 Takipçi
46 Takip Edilen
🚀 At Myllia Biotechnology, we're advancing scRNA-Seq in primary human cells with our targeted sequencing (TA-Seq) platform! Key insights: • TA-Seq uses 10K reads/cell vs. 50K reads/cell for WTA • Low-abundance mRNAs are detected more effectively with TA-Seq myllia.com
